“Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration”, Opthalmology, vol. 120, pp. 140-150, 2013.,
“Intravitreal Anti-Vascular Endothelial Growth Factor Therapy with Pegaptanib for Advanced Von Hippel-Lindau Disease of the Retina”, Retina, vol. 27, pp. 150-158, 2007.,
“Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease”, in Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2004.,
“Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy”, 2003.,
“Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration”, J Autoimmun, vol. 21, pp. 283-293, 2003.
“A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease”, 2003.,
“A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease”, 2003.,